THE ROLE OF METOCLOPRAMIDE IN ACUTE AND DELAYED CHEMOTHERAPY INDUCED EMESIS - A RANDOMIZED DOUBLE-BLIND TRIAL

被引:15
作者
OBRIEN, MER [1 ]
CULLEN, MH [1 ]
WOODROFFE, C [1 ]
KELLY, K [1 ]
BURMAN, C [1 ]
PALMER, K [1 ]
STUART, NSA [1 ]
BLACKLEDGE, GRP [1 ]
SHARPE, J [1 ]
机构
[1] QUEEN ELIZABETH HOSP,CANC RES CAMPAIGN,CLIN TRIALS UNIT,BIRMINGHAM B15 2TH,W MIDLANDS,ENGLAND
关键词
D O I
10.1038/bjc.1989.354
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:759 / 763
页数:5
相关论文
共 23 条
[1]   DEXAMETHASONE AND HIGH-DOSE METOCLOPRAMIDE - EFFICACY IN CONTROLLING CISPLATIN INDUCED NAUSEA AND VOMITING [J].
ALLAN, SG ;
CORNBLEET, MA ;
WARRINGTON, PS ;
GOLLAND, IM ;
LEONARD, RCF ;
SMYTH, JF .
BRITISH MEDICAL JOURNAL, 1984, 289 (6449) :878-879
[2]   DEFINITIONAL ISSUES IN THE STUDY OF ANTICIPATORY NAUSEA IN CANCER-CHEMOTHERAPY [J].
ANDRYKOWSKI, MA .
JOURNAL OF BEHAVIORAL MEDICINE, 1986, 9 (01) :33-41
[3]  
BAKER JJ, 1979, NEW ENGL J MED, V301, P728
[4]   ANTIEMETIC PROPHYLAXIS WITH HIGH-DOSE METOCLOPRAMIDE OR LORAZEPAM IN VOMITING INDUCED BY CHEMOTHERAPY [J].
BOWCOCK, SJ ;
STOCKDALE, AD ;
BOLTON, JAR ;
KANG, AA ;
RETSAS, S .
BRITISH MEDICAL JOURNAL, 1984, 288 (6434) :1879-1879
[5]  
BREITBART W, 1986, NEW ENGL J MED, V315, P518
[6]   ON THE RECEIVING END PATIENT PERCEPTION OF THE SIDE-EFFECTS OF CANCER-CHEMOTHERAPY [J].
COATES, A ;
ABRAHAM, S ;
KAYE, SB ;
SOWERBUTTS, T ;
FREWIN, C ;
FOX, RM ;
TATTERSALL, MHN .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (02) :203-208
[7]  
DRAPKIN RL, 1982, P AN M AM SOC CLIN, pC236
[8]  
FETTING JH, 1983, CANCER TREAT REP, V67, P1093
[9]  
FRIEDLANDER ML, 1983, LANCET, V2, P686
[10]  
GRALLA RJ, 1980, P AM ASSOC CANC RES, V21, P350